Viridian Therapeutics, Inc.\DE (VRDN) Net Margin (2016 - 2025)
Historic Net Margin for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Q3 2025 value amounting to 49.67%.
- Viridian Therapeutics, Inc.\DE's Net Margin rose 888968400.0% to 49.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 427.3%, marking a year-over-year increase of 846352800.0%. This contributed to the annual value of 89387.09% for FY2024, which is 136756200.0% down from last year.
- Per Viridian Therapeutics, Inc.\DE's latest filing, its Net Margin stood at 49.67% for Q3 2025, which was up 888968400.0% from 134313.33% recorded in Q2 2025.
- In the past 5 years, Viridian Therapeutics, Inc.\DE's Net Margin ranged from a high of 49.67% in Q3 2025 and a low of 134313.33% during Q2 2025
- Over the past 5 years, Viridian Therapeutics, Inc.\DE's median Net Margin value was 66194.44% (recorded in 2023), while the average stood at 53169.89%.
- Per our database at Business Quant, Viridian Therapeutics, Inc.\DE's Net Margin crashed by -649564700bps in 2023 and then soared by 888968400bps in 2025.
- Viridian Therapeutics, Inc.\DE's Net Margin (Quarter) stood at 13526.17% in 2021, then crashed by -222bps to 43604.76% in 2022, then crashed by -113bps to 92861.11% in 2023, then fell by -19bps to 110809.72% in 2024, then skyrocketed by 100bps to 49.67% in 2025.
- Its Net Margin was 49.67% in Q3 2025, compared to 134313.33% in Q2 2025 and 120711.11% in Q1 2025.